Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2013

Oct 21, 2013

32939_dirs_2013-10-21_1bdd1f0c-2435-45f3-a72f-a237964cdee8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2013-10-17

Reporting Person: DONNELLY HOWARD W (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-10-17 Common Stock M 20000 $11 Acquired 35850 Direct
2013-10-17 Common Stock S 20000 $15.06 Disposed 15850 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-10-17 Non-Qualified Stock Option (right to buy) $11 M 20000 Disposed 2014-05-26 Common Stock (20000) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.23, inclusive. The options exercised to purchase the shares were granted on 5/26/2004 and were set to expire on 5/26/2014. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1.

F2: Options for 25% of the shares became exercisable on 5/26/2005, 5/26/2006, 5/26/2007 and 5/26/2008.